NO20005556L - PTH 2 reseptor-selektive forbindelser - Google Patents

PTH 2 reseptor-selektive forbindelser

Info

Publication number
NO20005556L
NO20005556L NO20005556A NO20005556A NO20005556L NO 20005556 L NO20005556 L NO 20005556L NO 20005556 A NO20005556 A NO 20005556A NO 20005556 A NO20005556 A NO 20005556A NO 20005556 L NO20005556 L NO 20005556L
Authority
NO
Norway
Prior art keywords
pth
abnormal
selective compounds
receptor selective
functions
Prior art date
Application number
NO20005556A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005556D0 (no
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Beth Israel Hospital filed Critical Sod Conseils Rech Applic
Publication of NO20005556D0 publication Critical patent/NO20005556D0/no
Publication of NO20005556L publication Critical patent/NO20005556L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005556A 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser NO20005556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05
PCT/US1999/009521 WO1999057139A2 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Publications (2)

Publication Number Publication Date
NO20005556D0 NO20005556D0 (no) 2000-11-03
NO20005556L true NO20005556L (no) 2001-01-03

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005556A NO20005556L (no) 1998-05-05 2000-11-03 PTH 2 reseptor-selektive forbindelser

Country Status (12)

Country Link
US (2) US7531621B1 (https=)
EP (1) EP1075491B1 (https=)
JP (1) JP4460157B2 (https=)
AT (1) ATE392431T1 (https=)
AU (1) AU3673699A (https=)
CA (1) CA2327509A1 (https=)
DE (1) DE69938548T2 (https=)
ES (1) ES2302374T3 (https=)
HU (1) HUP0300891A2 (https=)
NO (1) NO20005556L (https=)
PL (1) PL344645A1 (https=)
WO (1) WO1999057139A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK40599A3 (en) 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
WO1998051329A1 (en) 1997-05-15 1998-11-19 Chugai Seiyaku Kabushiki Kaisha Cachexia remedy
WO2001002011A1 (fr) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha REMEDES CONTRE LES MALADIES CAUSEES PAR PTH OU PTHrP
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
US8029793B2 (en) 2000-04-28 2011-10-04 Chugai Seiyaku Kabushiki Kaisha Methods for inhibiting cell proliferation
WO2002024943A2 (en) * 2000-09-19 2002-03-28 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
AU2007313001B2 (en) 2006-10-13 2012-03-22 Eli Lilly And Company Pegylated PTH as PTH receptor modulators and uses thereof
AU2008282805B2 (en) 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
EP0341962B1 (en) 1988-05-09 1995-03-15 Merck & Co. Inc. Humoral hypercalcemic factor antagonists
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
AU9103791A (en) * 1990-12-21 1992-07-22 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
DE69734157T2 (de) 1996-07-31 2006-07-13 The General Hospital Corp., Boston Parathyroidhormon-verwandthe peptidanaloge

Also Published As

Publication number Publication date
NO20005556D0 (no) 2000-11-03
US20090226477A1 (en) 2009-09-10
ES2302374T3 (es) 2008-07-01
DE69938548T2 (de) 2009-06-18
EP1075491B1 (en) 2008-04-16
JP4460157B2 (ja) 2010-05-12
US7531621B1 (en) 2009-05-12
HUP0300891A2 (hu) 2003-07-28
PL344645A1 (en) 2001-11-19
DE69938548D1 (de) 2008-05-29
AU3673699A (en) 1999-11-23
WO1999057139A3 (en) 2000-02-03
ATE392431T1 (de) 2008-05-15
CA2327509A1 (en) 1999-11-11
WO1999057139A2 (en) 1999-11-11
EP1075491A2 (en) 2001-02-14
JP2002513801A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
NO20005556L (no) PTH 2 reseptor-selektive forbindelser
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
MXPA03004832A (es) Compuestos y sus usos.
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
ATE256671T1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)- piperazin-derivate
YU33802A (sh) Policikloalkilpurini kao antagonisti adenozinskih receptora
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
NO20072352L (no) Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet
BRPI0517039A (pt) método de flexão de materiais folha e respectiva folha
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
SE0201448D0 (sv) Method for reducing methane production emanating from the digestive activites of an animal
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
DK1789019T3 (da) Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse
NO943133D0 (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
GB9815618D0 (en) Treatment of dyskinesia
DE60313132D1 (de) Anschnittsystem für reduzierung von spritzmasseaustritt aus dem angusskanal
ID27771A (id) Turunan triazol-piridazin tersubstitusi, komposisi farmasi yang dibuat dari bahan itu
NO20022471L (no) Kontinuerlig fremgangsmåte for produksjon av individuelle flak for en kontinuerlig bane
UA103594C2 (ru) Способ лечения увеита
SE9702794D0 (sv) New compounds
NO974256L (no) Anvendelse av anti-östrogener som befruktningshindrende midler for menn
WO2004009097A3 (fr) Utilisation d'un analogue du nad, substrat des mono-adp-ribosyl transferases et antagoniste du nad, pour la preparation d'un medicament destine au traitement des pathologies liees aux recepteurs purinergiques

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application